Michael LeBlanc Selected Research

Michael LeBlanc Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 02/2003
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 09/2003
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2018 - 09/2003
6	Lymphoma (Lymphomas) 01/2022 - 06/2004
6	Hodgkin Disease (Hodgkin's Disease) 10/2020 - 08/2003
6	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 07/2004
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2004
4	B-Cell Lymphoma (Lymphoma, B Cell) 10/2016 - 06/2004
2	Leukemia 10/2016 - 06/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 07/2015 - 01/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015 - 10/2007
2	Squamous Cell Carcinoma of Head and Neck 04/2011 - 07/2010
1	Frailty 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Coma (Comas) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Heart Diseases (Heart Disease) 10/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2017
1	Lung Diseases (Lung Disease) 10/2017
1	Pain (Aches) 10/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016
1	Mycosis Fungoides 07/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2015
1	Lung Neoplasms (Lung Cancer) 04/2015
1	Stomach Neoplasms (Stomach Cancer) 02/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2014
1	Disease Progression 10/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2013
1	Medulloblastoma 05/2012
1	Pathologic Complete Response 07/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2008

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 03/2018 - 05/2008
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2003
6	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 09/2003
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2003
6	Prednisone (Sone)FDA LinkGeneric 01/2018 - 09/2003
4	Finasteride (Propecia)FDA LinkGeneric 11/2019 - 07/2004
3	Biological ProductsIBA 01/2022 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2015
2	ChemokinesIBA 01/2019 - 02/2015
2	CytokinesIBA 01/2019 - 02/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2012
2	IodineIBA 01/2018 - 09/2003
2	Gemcitabine FDA Link 08/2014 - 01/2013
2	Etoposide (VP 16)FDA LinkGeneric 01/2013 - 11/2005
2	InterferonsIBA 07/2008 - 11/2005
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	AndrogensIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	trans-crotonin (CTN)IBA 01/2018
1	Vorinostat FDA Link 01/2018
1	Histocompatibility Antigens Class IIIBA 10/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016
1	belinostatIBA 10/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Aurora Kinase AIBA 07/2015
1	MLN 8237IBA 07/2015
1	Aurora Kinase BIBA 07/2015
1	Vitamin D FDA LinkGeneric 05/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2015
1	Docetaxel (Taxotere)FDA Link 02/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2013
1	Methylprednisolone FDA LinkGeneric 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Anaplastic Lymphoma KinaseIBA 01/2013
1	Bevacizumab (Avastin)FDA Link 08/2012
1	IPI-926IBA 05/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012
1	eribulin FDA Link 04/2011
1	TubulinIBA 04/2011
1	halichondrin BIBA 04/2011
1	Sorafenib (BAY 43-9006)FDA Link 07/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2008
1	Monoclonal AntibodiesIBA 11/2005
1	Mechlorethamine (Nitrogen Mustard)FDA Link 11/2005
1	Procarbazine (Matulane)FDA Link 11/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2003
10	Drug Therapy (Chemotherapy) 01/2022 - 09/2003
5	Radiotherapy 10/2020 - 09/2003
2	Aftercare (After-Treatment) 10/2019 - 01/2018
2	Autologous Transplantation 01/2019 - 10/2013
2	Radioimmunotherapy 03/2018 - 01/2018
2	Chemoprevention 01/2018 - 12/2003
1	Immunotherapy 01/2022
1	Cell Transplantation 01/2018
1	Activities of Daily Living (ADL) 10/2017
1	Self Medication 10/2017
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016
1	Castration 02/2015
1	Transplantation 10/2013
1	Stem Cell Transplantation 10/2013
1	Laryngectomy 10/2007
1	Tracheostomy 10/2007
1	Gas Lasers 10/2007